Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Stock
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
31.1M
-
Shares change
-
+12.3M
-
Total reported value, excl. options
-
$39.5M
-
Value change
-
+$12.4M
-
Number of buys
-
27
-
Number of sells
-
-18
-
Price
-
$1.27
Significant Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q4 2021
58 filings reported holding CDTX - CIDARA THERAPEUTICS INC COM NEW - Stock as of Q4 2021.
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.1M shares
.
Largest 10 shareholders include BVF INC/IL (6.86M shares), Nantahala Capital Management, LLC (5.27M shares), Point72 Asset Management, L.P. (4.2M shares), VANGUARD GROUP INC (2.48M shares), Stonepine Capital Management, LLC (2.31M shares), ALETHEA CAPITAL MANAGEMENT, LLC (1.94M shares), RENAISSANCE TECHNOLOGIES LLC (1.41M shares), 5AM Venture Management, LLC (1.13M shares), ACADIAN ASSET MANAGEMENT LLC (889K shares), and TWO SIGMA ADVISERS, LP (546K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.